Lung cancer Clinical Trials
Recruiting lung cancer studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat lung cancer. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting lung cancer studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting lung cancer trials
Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records
Dissemination Of Lung Cancer Screening Education Through Tobacco Quitlines
Respiratory Muscle Training in Patients Undergoing Lung Cancer Surgery
An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial
Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial
Totally Robotic Versus Surgeon-Assisted Robotic Lung Resection For Early-Stage NSCLC
Vapor Ablation for Localized Cancer Lesions
Population Health Management -Increase Lung Cancer Screening in Community Health Centers (LungSMART)
A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
Home-Based Respiratory Muscle Training and Aerobic Exercise Programs to Improve Lung Health in Current and Former Cigarette Smokers
Two-Point Versus Single-Point Serratus Anterior Plane Block for Post-Thoracoscopic Surgery Analgesia
Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study
AIRCARE (Air Pollution and Cancer Research Ecosystem): Center for Advanced Research on Environmental Health and Lung Cancer Risk
Observational Study That Will Analyse the Spread and Stratification of Lung Cancer Risk Using Artificial Intelligence
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Label-free Femtosecond Laser Imaging Combined With the Fast Lung Artificial Intelligence Model for Rapid Intraoperative Diagnosis of Lung Surgical Specimens: A Multicentre, Prospective, Parallel-workflow, Non-inferiority Study.
Testing the SurVaxM Vaccine for Lung Cancer Prevention
A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial
Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized Controlled Trial in Hong Kong
Statewide Unified Network for Remote Intervention of Strength and Exercise
Impact of a Reminder App on Physical Activity During Radiation Therapy for Lung Cancer
Modulatory Effect of Prodigiosin or Pioglitazone on TIME and the Crosstalk to Immune-Checkpoint Protein(s)
Optimizing Patient Treatment With EPA-enriched Nutrition, a Randomised Control Trial
Lung Cancer Screening Implementation Project in the Brazilian Public Health Care System (LUSIP)
SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Classifier
Clinical Study on the Effects of Pulmonary Vessels on Cryoablation and Preventive Embolization Strategies
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or Metastatic NSCLC
Precision Navigation to Improve Community Cancer Screening Participation
LUCINAE Registry: Thoracic Cancers During Pregnancy
A Study of Lung Cancer Risk
Real-World Outcomes of Resected EGFR-Mutated NSCLC Patients Treated With Adjuvant EGFR-TKI in China
PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLC
CHAMP Lung Cancer Screening Program
Understanding the Feasibility of a Co-designed Pre-radiotherapy Exercise Programme - A Single-arm Study
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Antigen-specific T Cells Against Lung Cancer
Prediction Augmented Screening Initiative
5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Peripheral Vascular Disease as a Clinical Trigger for Opportunistic Lung Cancer Screening Referral: An Implementation Study
Effects of Infusion Timing on Treatment Response in Solid Tumors
A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
Association Between Screening Behaviors and Lung Cancer Spectrum
Implementing Low-dose ct Lung Cancer Screening in France.
The Effect of Mindfulness-Based Breathing Exercises on Dyspnea, Symptom Control, and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy
A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and Palonosetron
A Clinical Study to Evaluate the Pharmacokinetics and Safety of Anecatibin Fumarate Capsules in Subjects With Impaired Liver Function Versus Normal Liver Function
Indian Lung Screening Trial
Axelopran for Advanced Cancer in Patients Receiving Opioids
Social Optimization Study
Identification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Pulmonary Neoplasia
CARE Tool Study Aim 3
3D Virtual Resection for Predicting Lung Function in VATS
Precision Physical Exercise for Personalized Onco-Hematology.
Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study
Lungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in Canada
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity
Lung cancer clinical trials — common questions
Are lung cancer clinical trials free to join?
Yes. Participating in a lung cancer clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a lung cancer clinical trial?
Each lung cancer study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a lung cancer trial near me?
Use the location controls above. We'll show recruiting lung cancer trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many lung cancer trials are recruiting right now?
We're currently tracking roughly 193 recruiting lung cancer trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.